LeoPharma and Morphosys join forces to fight skin diseases
LEO Pharma and MorphoSys AG have entered into a strategic alliance for the discovery and development of therapeutic antibodies for the treatment…
Pharmaceuticals, Biotechnology and Life Sciences
LEO Pharma and MorphoSys AG have entered into a strategic alliance for the discovery and development of therapeutic antibodies for the treatment…
Mereo reports positive outcome of its phase 1 study of acute exacerbations of COPD drug
Strides and Mylan have agree to settle Regulatory and General Claims on Agila transaction.
Allergan has completed its initial $5 billion in share repurchases under its previously announced share repurchase program…
GE Healthcare and Valneva have joined forces to create cell culture medium for vaccine
Abzena has issued a statement in which it notes that during the conference call to accompany Gilead Sciences Inc.’s (‘Gilead’) announcement of third quarter
Targovax CEO has stepped down, current CFO takes the role
European Patent Office OKs new patent for Allergy Therapeutics’ Microcrystalline Tyrosine tech
Ajanta Pharma has gotten US FDA’s approval to launch its high blood pressure tablets Amlodipine